๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Time to Prostate-Specific Antigen Nadir After Androgen Suppression Therapy for Postoperative or Postradiation PSA Failure and Risk of Prostate Cancer-Specific Mortality

โœ Scribed by Andriole, G.L.

Book ID
123250690
Publisher
Elsevier Science
Year
2008
Weight
74 KB
Volume
2008
Category
Article
ISSN
0084-4071

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Time to an undetectable prostate-specifi
Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality
โœ Anthony V. D'Amico; David G. McLeod; Peter R. Carroll; Jennifer Cullen; Ming-Hui ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB

## Abstract ## BACKGROUND For men receiving androgenโ€suppression therapy (AST) for a rising postoperative or postradiation prostateโ€specific antigen (PSA) recurrence, whether the time to an undetectable (u) PSA was significantly associated with prostate cancerโ€specific mortality (PCSM) was evaluat

Influence of body mass index on prostate
Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer
โœ Jason A. Efstathiou; Ming-Hui Chen; Andrew A. Renshaw; Marian J. Loffredo; Antho ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostateโ€specific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio